Ravi Jahagirdar

RVX-208

Dana Bailey, Ravi Jahagirdar, Allan Gordon et al. · Journal of the American College of Cardiology · 2010 · 228 citations

Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension

Diederik E. van der Feen, Kondababu Kurakula, Ève Tremblay et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 158 citations · Full text

A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice

Ravi Jahagirdar, Haiyan Zhang, Salman Azhar et al. · Atherosclerosis · 2014 · 130 citations

Inflammation, Metabolic Syndrome, Oxysterol +11

Peroxisome proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice

Rai Ajit K. Srivastava, Ravi Jahagirdar, Salman Azhar et al. · Molecular and Cellular Biochemistry · 2006 · 97 citations

Ldl Receptor-deficient Mice, Insulin Signaling, Oxidative Stress +17

Apabetalone downregulates factors and pathways associated with vascular calcification

Dean Gilham, Laura Tsujikawa, Christopher D. Sarsons et al. · Atherosclerosis · 2018 · 65 citations · Full text